FDA and EU clear Zap Surgical’s radiosurgery planning system
November 11, 2025
Zap Surgical’s ZAP Axon system aims to make radiosurgery planning more straightforward and efficient.
Zap Surgical’s ZAP Axon system aims to make radiosurgery planning more straightforward and efficient.
Go-Pen announced today on social media that it received CE mark approval for its user-fillable insulin pen.
University of Mississippi researchers have developed a new tool to help scientists study how environmental and genetic factors interact to influence autism spectrum disorder.
Four University of Rhode Island researchers have developed and tested a cost-effective, easy-to-use tabletop device that can generate pressure waves, mimicking the impact of blasts that can cause neurodegeneration. Their study was recently published in the journal Cell Reports Methods. The results will help URI’s Claudia Fallini and Riccardo Sirtori better study the development and progression of neurodegenerative diseases in their lab.
Rice University bioengineers have demonstrated a nonsurgical way to quiet a seizure-relevant brain circuit in an animal model. The team used low-intensity focused ultrasound to briefly open the blood-brain barrier (BBB) in the hippocampus, delivered an engineered gene therapy only to that region and later flipped an on-demand “dimmer switch” with an oral drug.
Sentante today announced the completion of a first-of-its-kind remote stroke procedure in Scotland using its robotic platform.
Stereotaxis (NYSE:STXS) announced today that it received FDA 510(k) clearance for its next-generation GenesisX surgical robot.
Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received FDA approval for the Android version of its Mobi mobile app
Epilepsy is the world’s most common chronic neurological condition, affecting about 1 in every 100 people. Those who have it go into seizures of varying intensity, ranging from barely noticeable to dramatic, with convulsions and loss of consciousness.
Stanford Health Policy researchers built a model to test whether AI could effectively manage disease spread between prisons and surrounding communities. The results were decisive.